Medical News

RSS

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

NanoPacific Holdings, Inc. (NPH) announces the acquisition of an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies. Under the terms of the agreement between NPH and UCLA, NPH will have an exclusive worldwide license of a system composed of a ternary mixture of modular components that self-assemble into supramolecular nanoparticles.

9 Dec 2009

NYSE Amex to delist Cortex Pharmaceuticals

Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company’s non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company’s common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.

9 Dec 2009

Watson Pharmaceuticals' RAPAFLO demonstrates safety and tolerability in BPH treatment

Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.

9 Dec 2009

Hi-Tech Pharmacal reports net sales of $40.9M for the quarter ended October 31, 2009

Hi-Tech Pharmacal Co., Inc. today reported results for the quarter ended October 31, 2009.

9 Dec 2009

Waters begins shipping its ground-breaking SYNAPT G2 Mass Spectrometer

Waters Corporation announced today that it has shipped the first units of its ground-breaking SYNAPT(TM) G2 Mass Spectrometer, first introduced at the 2009 American Society of Mass Spectrometry (ASMS) annual conference in Philadelphia in June.

9 Dec 2009

CORD:USE Cord Blood Bank awarded contract to supply blood units for the NCBI

CORD:USE Cord Blood Bank is proud to announce that the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services has awarded CORD:USE Cord Blood Bank a three-year, multi-million dollar contract to expand the supply of cord blood units for the National Cord Blood Inventory (NCBI).

9 Dec 2009

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Osteologix Inc. announced today that the company anticipates that it will be prepared to file a marketing application in 2011 in the European Union for its proprietary second-generation strontium therapy, NB S101 (strontium malonate). If successful, this will be Osteologix' first marketing approval of NB S101 for the treatment of postmenopausal osteoporosis.

9 Dec 2009

Unigene Laboratories announces reduction in workforce and operating expenses

Unigene Laboratories, Inc. has announced a restructuring plan that includes a reduction in workforce to improve operational efficiencies and to better match resources with market demand and the Company’s strategic objectives.

9 Dec 2009

PHYH spins off Phyhealth Corporation

Physicians Healthcare Management Group, Inc., today announced that it is spinning off its wholly-owned subsidiary, Phyhealth Corporation ("Phyhealth"). Phyhealth will assume substantially all the businesses, assets and liabilities of PHYH at the time of, or prior to, the spin-off.

9 Dec 2009

National Health Partners to generate record revenue of between $1.5 and $2 million during the first-fiscal

National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, announced today that it expects to generate record revenue and positive cash flow from operating activities during its fiscal quarter ended March 31, 2010 due to the successful launch of several large-scale sales campaigns by its partners.

9 Dec 2009

Varian Medical Systems receives IDG's InfoWorld 100 Award for innovative use of IT

Zenprise, Inc., a provider of mobile management software, today announced its customer, Varian Medical Systems Inc., received IDG's InfoWorld 100 Award based on its deployment of the Zenprise MobileManager platform. The InfoWorld 100 Awards recognizes the top 100 most innovative uses of IT initiatives to further business goals.

9 Dec 2009

Newly created line of skin care products based on ISCO’s proprietary Parthenogenic Stem Cells

Lifeline Skin Care, Inc, a wholly owned subsidiary of International Stem Cell Corporation, announced today that it has retained the services of a highly experienced expert in the skin care industry, Raulee Marcus, to help design a marketing program for its newly created line of skin care products based on ISCO’s proprietary Parthenogenic Stem Cells.

9 Dec 2009

Protalix Biotherapeutics completes NDA submission for taliglucerase alfa

Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application (NDA) submission with the U.S. Food and Drug Administration (FDA) for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for the potential treatment of Gaucher’s disease.

9 Dec 2009

UnitedHealthcare improves access to health care with DocGPS App of Apple’s iPhone

UnitedHealthcare is helping improve access to health care by putting its vast network of doctors, clinics, hospitals and other health care services on a new app just introduced on Apple’s iPhone.

9 Dec 2009

BCBSNC to implement Callidus Software's Monaco Suite

Callidus Software Inc., the leader in Sales Performance Management (SPM), today announced that Blue Cross Blue Shield of North Carolina (BCBSNC), has selected the Callidus Monaco Suite to manage sales performance and incentive compensation programs. Under the enterprise class SaaS agreement, signed in the third quarter of 2009, BCBSNC will use the Callidus Monaco Suite for its 4,000 brokers.

9 Dec 2009

TRYTON-LM clinical study enrolls first two patients

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott’s XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.

9 Dec 2009

Spectrum Pharmaceuticals recognized as one of the Top Work Places in Orange County

Spectrum Pharmaceuticals (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, today announced that it has been ranked by the Orange County Register as one of Orange County’s Top Work Places for 2009.

9 Dec 2009

SC Magazine names BIO-key International as 2009 Innovator of the Year in Biometrics

BIO-key International, Inc., a leader in finger-based biometric identification solutions, today announced that SC Magazine, one of the world's most respected security publications, named BIO-key International the 2009 Innovator of the Year in the Access Control sub-category Biometrics.

9 Dec 2009

Novartis presents 6-month results from its EVEREST study for PCV

QLT Inc. welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented during a scientific review today by Novartis in Basel, Switzerland.

9 Dec 2009

CIDR utilizes Isilon scale-out NAS for genotyping and statistical genetics services

Isilon Systems today announced that the Center for Inherited Disease Research (CIDR) at Johns Hopkins University is using Isilon scale-out NAS to power its leading-edge genotyping and statistical genetics services, which generate up to three terabytes of new data per day.

9 Dec 2009

Medical News

NPH acquires an exclusive license from UCLA for a suite of supramolecular nanoparticle technologies

NYSE Amex to delist Cortex Pharmaceuticals

Watson Pharmaceuticals' RAPAFLO demonstrates safety and tolerability in BPH treatment

Hi-Tech Pharmacal reports net sales of $40.9M for the quarter ended October 31, 2009

Waters begins shipping its ground-breaking SYNAPT G2 Mass Spectrometer

CORD:USE Cord Blood Bank awarded contract to supply blood units for the NCBI

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Unigene Laboratories announces reduction in workforce and operating expenses

PHYH spins off Phyhealth Corporation

National Health Partners to generate record revenue of between $1.5 and $2 million during the first-fiscal

Varian Medical Systems receives IDG's InfoWorld 100 Award for innovative use of IT

Newly created line of skin care products based on ISCO’s proprietary Parthenogenic Stem Cells

Protalix Biotherapeutics completes NDA submission for taliglucerase alfa

UnitedHealthcare improves access to health care with DocGPS App of Apple’s iPhone

BCBSNC to implement Callidus Software's Monaco Suite

TRYTON-LM clinical study enrolls first two patients

Spectrum Pharmaceuticals recognized as one of the Top Work Places in Orange County

SC Magazine names BIO-key International as 2009 Innovator of the Year in Biometrics

Novartis presents 6-month results from its EVEREST study for PCV

CIDR utilizes Isilon scale-out NAS for genotyping and statistical genetics services

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News